戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 rtially restored cell survival and conferred radioprotection.
2 eukin-1 receptor signaling, are critical for radioprotection.
3  iodide uptake in the thyroid may be used in radioprotection.
4 ective and selective strategy for intestinal radioprotection.
5 ith PD treatment for even greater intestinal radioprotection.
6 interleukin-7 prior to irradiation conferred radioprotection.
7 chanism of growth factor-mediated intestinal radioprotection.
8 appear to contribute to subsequent cutaneous radioprotection.
9 elets, or both are the critical effectors of radioprotection.
10 lic reprogramming by PKCdelta contributes to radioprotection.
11 reports and complying with the principles of radioprotection.
12 ne was also evaluated in mice as a model for radioprotection.
13 diation research, including space travel and radioprotection.
14 oradiography and could demonstrate a partial radioprotection.
15 ts that melanin also plays a pivotal role in radioprotection.
16         GT3-Nano demonstrated dose-dependent radioprotection, achieving 90% survival at 50 mg/kg agai
17 essing STAT1alpha and STAT1beta demonstrated radioprotection after exposure to 3 Gy (P < 0.038).
18 ods for reagent purification, drug labeling, radioprotection and chromatographic purification.
19 after lethal total body irradiation provides radioprotection and gives rise to long-term hematopoieti
20 blood cell lineages: one that generates both radioprotection and long-term engraftment and one that p
21 ted that mouse LHSC are responsible for both radioprotection and long-term repopulation of all blood
22 ic Energy Agency and the French Institute of Radioprotection and Nuclear Safety.
23  However, HO-1(+/-) HSCs were ineffective in radioprotection and serial repopulation of myeloablated
24                  However, these cells lacked radioprotection and spleen colony-forming activity.
25       Furthermore, oral WR-2721 confers full radioprotection and survival after lethal upper abdomina
26 Cs migrated to BM, self-replicated, provided radioprotection, and established long-term hematopoietic
27    Mouse models of SCF-mediated anaphylaxis, radioprotection, and hematopoietic expansion revealed th
28 in homing: PTX-treated cells did not provide radioprotection, and their short-term engraftment in BM
29 nstrate a nonredundant function of GM-CSF in radioprotection by donor hematopoietic cells that may pr
30               Here we show that TKIs mediate radioprotection by increasing the repair of DNA double-s
31             In addition, local muscle tissue radioprotection by lead shielding during irradiation pre
32                           Here, we show that radioprotection can be conferred by damage-derived exoso
33 Cs results in diminished pool size, impaired radioprotection, defective repopulation, and loss of qui
34                                          The radioprotection efficacy of GT3-Nano was assessed after
35                                         This radioprotection enables ablative radiation therapy in a
36 ross most of Europe prompted the Institut de Radioprotection et de Surete Nucleaire (IRSN) to analyze
37  Occupational Safety and Health, Institut de Radioprotection et de Surete Nucleaire, Orano, Electrici
38 quired and specific for erythroid short-term radioprotection following bone marrow transplantation.
39  promotes HSC regeneration and hematopoietic radioprotection following total body irradiation.
40 nt oral delivery system to achieve effective radioprotection for the whole small intestine, providing
41  genetic radionuclide therapy, and free-flap radioprotection, have the potential to extend the role o
42 roved rectal delivery of GM-0111 to mice and radioprotection in a RIP model.
43                      DMA showed an excellent radioprotection in mice at single nontoxic oral dose by
44 or glutaminase prior to irradiation reversed radioprotection in PKCdelta-depleted cells, indicating t
45 - c-kit+ Sca-1- cells (CD31+ Sca-1-) provide radioprotection in the absence of long-term donor-derive
46 mine and nucleotide synthesis contributes to radioprotection in the context of PKCdelta inhibition.
47 ly, Toll-like receptor 5 stimulation confers radioprotection in the intestine.
48 entify IKKbeta as a key molecular target for radioprotection in the intestine.
49 omprehensive drug accumulation and effective radioprotection in the whole small intestine that is sig
50                 A possible role for TLK1B in radioprotection is discussed.
51 e mechanism of Amifostine (WR-2721) mediated radioprotection is poorly understood.
52 ration of these metabolites caused long-term radioprotection, mitigation of hematopoietic and gastroi
53 may provide an insight into the mechanism of radioprotection of BIO 300 and a reasonable illustration
54 monstrated accelerated BM cellular recovery, radioprotection of BM c-kit(+)sca-1(-)lin(-) progenitors
55 erived bone marrow cells provides short-term radioprotection of lethally irradiated recipients, whose
56  orthotopic oral cancer, messenger RNA-based radioprotection of normal tissue preserved the efficacy
57 been postulated that the basis for selective radioprotection of normal tissues is greater bioreductio
58 e of thrombospondin-1 or CD47 provides local radioprotection of soft tissues and bone marrow.
59 ential molecular targets for pharmacological radioprotection of stem cells and hopefully improving th
60                            These mice showed radioprotection of the HSC pool and 100% survival after
61  role of the RNA binding protein apobec-1 in radioprotection of the intestine.
62 g in the inhibition of CUGBP2 expression and radioprotection of the intestine.
63 trate a dual mechanism by which TKIs provide radioprotection of the salivary gland tissues and suppor
64  hematopoietic cells and is critical for the radioprotection of these key cells.
65                 Furthermore, Endocan confers radioprotection on GBM cells in vitro and in vivo.
66 though RIBEs have important implications for radioprotection, radiation safety and radiotherapy, the
67 ate delayed multilineage engraftment, while "radioprotection" (rapid engraftment that will prevent ea
68  However, its oral application in intestinal radioprotection remains challenging.
69                           Flagellin-elicited radioprotection required TLR5, the TLR signaling adaptor
70 pulating stem cells from cells that provided radioprotection (short-term repopulating cells) on the b
71 amaging cancer therapies, and development of radioprotection strategies.
72 sense-mediated suppression of CUGBP2 renders radioprotection through a COX-2-dependent prostaglandin
73 am68-dependent NF-kappaB activation provides radioprotection to colon epithelium in vivo.
74 eserved an immature cell phenotype, provided radioprotection to lethally irradiated recipients, and e
75       CD47 blockade has been found to confer radioprotection to normal tissues while enhancing tumor
76 n if clearance of radioactivity relevant for radioprotection was achieved.
77                                         This radioprotection was at least partially specific for norm
78        Furthermore, a metabolic signature of radioprotection was observed through the use of amifosti
79                           Flagellin-elicited radioprotection was, in part, mediated via effects on ce
80          The effects of PHD inhibition on GI radioprotection will be described in detail.
81 nistration of rIL-11 resulted in significant radioprotection with 89% of the rIL-11-treated animals s